全文获取类型
收费全文 | 1173篇 |
免费 | 73篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 53篇 |
妇产科学 | 30篇 |
基础医学 | 63篇 |
口腔科学 | 20篇 |
临床医学 | 64篇 |
内科学 | 280篇 |
皮肤病学 | 52篇 |
神经病学 | 85篇 |
特种医学 | 49篇 |
外科学 | 183篇 |
综合类 | 37篇 |
一般理论 | 2篇 |
预防医学 | 82篇 |
眼科学 | 102篇 |
药学 | 102篇 |
中国医学 | 1篇 |
肿瘤学 | 48篇 |
出版年
2024年 | 1篇 |
2023年 | 9篇 |
2022年 | 32篇 |
2021年 | 49篇 |
2020年 | 24篇 |
2019年 | 40篇 |
2018年 | 47篇 |
2017年 | 29篇 |
2016年 | 49篇 |
2015年 | 54篇 |
2014年 | 54篇 |
2013年 | 96篇 |
2012年 | 121篇 |
2011年 | 130篇 |
2010年 | 73篇 |
2009年 | 54篇 |
2008年 | 79篇 |
2007年 | 61篇 |
2006年 | 48篇 |
2005年 | 49篇 |
2004年 | 47篇 |
2003年 | 31篇 |
2002年 | 36篇 |
2001年 | 3篇 |
2000年 | 3篇 |
1999年 | 8篇 |
1998年 | 5篇 |
1997年 | 4篇 |
1996年 | 1篇 |
1995年 | 1篇 |
1994年 | 3篇 |
1992年 | 1篇 |
1991年 | 3篇 |
1990年 | 1篇 |
1989年 | 2篇 |
1987年 | 1篇 |
1985年 | 2篇 |
1980年 | 3篇 |
1978年 | 1篇 |
1977年 | 1篇 |
排序方式: 共有1256条查询结果,搜索用时 15 毫秒
1.
2.
Seema Khan Smita Singhal Tarun Mathur Dilip J Upadhyay Ashok Rattan 《Nippon Ishinkin Gakkai Zasshi》2007,48(3):109-113
Disulfiram, an alcohol antagonistic drug has been on the market since 1949 with 80% bioavailability and an established safety profile. Recently it has been reported as a P-glycoprotein efflux pump modulator. Herein we report its antifungal potential. The MIC50 and MIC90 of disulfiram for yeast isolates is 4 and 8 microg/ml, respectively, and the MIC range is 1-16 micro g/ml for both fluconazole sensitive and resistant strains. Interestingly, disulfiram also showed fungicidal activity on Aspergillus spp. with MIC50 and MIC90 of 2 and 8 microg/ml, respectively. 相似文献
3.
Delay times and management of acute myocardial infarction in indigenous and non-indigenous people in the Northern Territory 总被引:2,自引:0,他引:2
OBJECTIVES: To investigate differences in presentation and management of Indigenous and non-Indigenous patients hospitalised with acute myocardial infarction (AMI). DESIGN: Retrospective review of hospital medical records. PARTICIPANTS AND SETTING: 122 patients with definite or possible AMI admitted to hospitals in the Top End of the Northern Territory (NT) in 1996. MAIN OUTCOME MEASURES: Percentage receiving thrombolytic therapy; delays from symptom onset to primary and emergency department presentations, first and diagnostic electrocardiograms, thrombolytic therapy and aspirin; drugs prescribed during hospitalisation. RESULTS: Thrombolytic therapy was given to 12/41 Indigenous patients (29%) and 38/81 non-Indigenous patients (47%) (P = 0.06). Presentation delay over 12 hours was the reason for not giving thrombolytic therapy for 14/29 Indigenous patients (48%) and 8/43 non-Indigenous patients (19%) (P < 0.01). Median delay times were longer for Indigenous patients for all six categories of delay, although the difference was significant only for delay to emergency department presentation (10:00 versus 3:26 hours; P < 0.01) and to diagnostic electrocardiogram (8:10 versus 3:50 hours; P < 0.01). Delays were also longer for patients from rural compared with urban areas. Once diagnosed, Indigenous patients were as likely as non-Indigenous patients to receive aspirin (93% versus 96%) and beta-blockers (70% versus 69%) and more likely to receive angiotensin-converting enzyme inhibitors (60% versus 40%; P = 0.03). CONCLUSIONS: Delays in presentation affect Indigenous people living in rural and urban areas as well as non-Indigenous people living in rural areas. Concerted efforts are needed to improve health service access in rural areas and to encourage Indigenous people with persistent chest pain to present earlier. 相似文献
4.
Prabhjot Kaur Tarun Garg Bhuvaneshwar Vaidya Atish Prakash Goutam Rath 《Journal of drug targeting》2015,23(3):275-286
This study was aimed for brain delivery of Tramadol HCl (centrally acting synthetic opioid) following intranasal administration for treatment of depression. Chitosan nanoparticles (NPs) were prepared by ionic gelation method followed by the addition of developed NPs with in the Pluronic and HPMC-based mucoadhesive thermo-reversible gel. Developed formulation optimized based on the various parameters such as particle size, entrapment efficiency, in vitro release study. Depression induction was done by forced swim test and evaluated by various behavioral and biochemical parameters. Furthermore, results showed significantly increased in locomotors activity, body weight as compared to control group. It also showed alteration in biochemical parameters such glutathione level and catalase levels significantly increased other than lipid peroxidation and nitrite level was found to be decreased after intranasal administration of formulation. Thus, intranasal TRM HCl NP-loaded in situ gel was found to be a promising formulation for the treatment of depression. 相似文献
5.
Glycyrrhetinic acid-modified chitosan (mGA-suc-CTS) is used as liver-targeted carrier for drug delivery. In this study, nanoparticles were prepared by ionic gelation process, and glycyrrhetinic acid act as the targeting ligand. The structure of the product was confirmed by IR and NMR techniques. The main aim of this study was to deliver atorvastatin directly to the liver by using same conjugate and reduce the associated side-effects, i.e. hepatotoxicity at high dose. Characterization of the developed formulation was performed by differential scanning calorimetry, particle size measurements and cellular uptake studies. Release profile, pharmacokinetics studies and organ distribution studies showed that developed formulation shows a relative higher liver uptake. The optimized formulation showed increased plasma concentration than the CTS nanoparticles as well as plain drug and the accumulation in the liver was nearly 2.59 times more than that of obtained with the CTS nanoparticles. Pharmaceutical and pharmacological indicators suggested that the proposed strategy can be successfully utilized for liver targeting of therapeutics. 相似文献
6.
7.
Purpose To determine the demand and preferences of infertility patients for sex selection for nonmedical reasons, and to investigate
the relation between these choices and their demographic and socioeconomic characteristics.
Methods A cross-sectional, self-administered survey by mail was conducted at a University hospital-based fertility center of 1,350
consecutive women who presented for infertility care, to assess patient demand and preferences for sex selection.
Results Of respondents, 49% wanted to select the sex of their next child for no added cost. Of these patients, 56% had no living children
and 37% had children all of one sex. After adjustment for observed predictors of gender preference, we found a significant
preference for a female child among women who had only sons, had more living children, or were single. Nulliparous women did
not significantly prefer one sex over the other. Among parous women, those with only daughters significantly desired to select
a male child, whereas those with sons significantly desired to select a female child.
Conclusion There is significant demand among infertility patients for preimplantation sex selection, with a significant portion of this
demand coming from patients who do not have any children or have children all of one sex.
Presented in part at the American Society for Reproductive Medicine (ASRM) Annual Meeting, New Orleans, Louisiana, October
2006.
Financial support: none
Conflict of interest: none 相似文献
8.
9.
10.